ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ADUS vs NEO // EV/EBITDA & P/E VALUATION

Addus HomeCare Corporation (NASDAQ) VS. NeoGenomics Inc. (NASDAQ) • 15-METRIC TALLY: ADUS 8 — NEO 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. NEO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ADUS NEO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 32.50% 43.20% -10.70 NEO /gross-margins <GO>
Return on Invested Capital (ROIC) 9.10% -9.00% +18.10 ADUS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 16.8x — — TIE /valuation <GO>
Free Cash Flow Yield 4.47% -0.94% +5.41 ADUS /fcf-yield <GO>
Operating Margin 9.70% -15.90% +25.60 ADUS /operating-margins <GO>
Net Profit Margin 6.70% -14.80% +21.50 ADUS /net-margins <GO>
Revenue Growth (YoY) 23.20% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.83 2.72 +3.11 ADUS /balance-sheet <GO>
Piotroski F-Score Quality 9/9 5/9 +4.00 ADUS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 73.1 51.0 +22.14 ADUS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 20.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.32B $2.32B $2.0M ADUS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ADUS REV NEO REV ADUS GROSS % NEO GROSS % ADUS FCF NEO FCF
FY 2025 $1.42B $727.3M 32.5% 43.2% $103.8M -$21.8M
FY 2024 $1.15B $660.6M 32.5% 43.9% $110.4M -$34.0M
FY 2023 $1.06B $0 — — $112.2M -$2.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
NEO // BETA —